Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth improved, but quality of life did not.

The treatment combination is effective and generally safe for lung cancer.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

The drug combination was safe and showed promise in treating advanced tumors.

Baricitinib was effective in treating both early and late onset alopecia areata.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

The document's conclusion cannot be provided because the content is not available.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.